VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback